c-Myc Represses Transcription of Epstein-Barr Virus Latent Membrane Protein 1 Early after Primary B Cell Infection

Recent evidence has shown that the Epstein-Barr virus (EBV) oncogene LMP1 is not expressed at high levels early after EBV infection of primary B cells, despite its being essential for the long-term outgrowth of immortalized lymphoblastoid cell lines (LCLs). In this study, we found that expression of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of virology 2018-01, Vol.92 (2)
Hauptverfasser: Price, Alexander M, Messinger, Joshua E, Luftig, Micah A
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 2
container_start_page
container_title Journal of virology
container_volume 92
creator Price, Alexander M
Messinger, Joshua E
Luftig, Micah A
description Recent evidence has shown that the Epstein-Barr virus (EBV) oncogene LMP1 is not expressed at high levels early after EBV infection of primary B cells, despite its being essential for the long-term outgrowth of immortalized lymphoblastoid cell lines (LCLs). In this study, we found that expression of LMP1 increased 50-fold between 7 days postinfection and the LCL state. Metabolic labeling of nascent transcribed mRNA indicated that this was primarily a transcription-mediated event. EBNA2, the key viral transcription factor regulating LMP1, and CTCF, an important chromatin insulator, were recruited to the LMP1 locus similarly early and late after infection. However, the activating histone H3K9Ac mark was enriched at the LMP1 promoter in LCLs relative to that in infected B cells early after infection. We found that high c-Myc activity in EBV-infected lymphoma cells as well as overexpression of c-Myc in an LCL model system repressed LMP1 transcription. Finally, we found that chemical inhibition of c-Myc both in LCLs and early after primary B cell infection increased LMP1 expression. These data support a model in which high levels of endogenous c-Myc activity induced early after primary B cell infection directly repress LMP1 transcription. EBV is a highly successful pathogen that latently infects more than 90% of adults worldwide and is also causally associated with a number of B cell malignancies. During the latent life cycle, EBV expresses a set of viral oncoproteins and noncoding RNAs with the potential to promote cancer. Critical among these is the viral latent membrane protein LMP1. Prior work suggests that LMP1 is essential for EBV to immortalize B cells, but our recent work indicates that LMP1 is not produced at high levels during the first few weeks after infection. Here we show that transcription of the LMP1 gene can be negatively regulated by a host transcription factor, c-Myc. Ultimately, understanding the regulation of EBV oncogenes will allow us to better treat cancers that rely on these viral products for survival.
doi_str_mv 10.1128/jvi.01178-17
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5752943</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1962428041</sourcerecordid><originalsourceid>FETCH-LOGICAL-c450t-7bcab07e7e960efaa4f023ac5666eac5c77da5122565de73668b196bbef2e613</originalsourceid><addsrcrecordid>eNpVkc1rGzEQxUVISBy3t5yLjjlkU41WH7uXQmPc1MWhpRjTm9DKs6nMencjrQP-7yvXTkhOAzM_3nvDI-QK2C0ALz6vn_0tA9BFBvqEjICVRSYliFMyYozzTObFnwtyGeOaMRBCiXNywUuAArgYkeCyh52jv7EPGCNGugi2jS74fvBdS7uaTvs4oG-zOxsCXfqwjXRuB2wH-oCbKtFIf4Vuj1CgUxuaHbX1gCFt_caGHb2jE2waOmtrdHvRD-Sstk3Ej8c5Jotv08Xkezb_eT-bfJ1nTkg2ZLpytmIaNZaKYW2tqBnPrZNKKUzDab2yEjiXSq5Q50oVFZSqqrDmqCAfky8H2X5bbXDlUuJgG9MfUpnOevP-0vq_5rF7NlJLXoo8CVwfBUL3tMU4mI2PLr2SXu620SQzLnjBxN7r5oC60MUYsH61AWb2LZkfy5n535IBnfBPb6O9wi-15P8ADBCPoA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1962428041</pqid></control><display><type>article</type><title>c-Myc Represses Transcription of Epstein-Barr Virus Latent Membrane Protein 1 Early after Primary B Cell Infection</title><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Price, Alexander M ; Messinger, Joshua E ; Luftig, Micah A</creator><contributor>Longnecker, Richard M.</contributor><creatorcontrib>Price, Alexander M ; Messinger, Joshua E ; Luftig, Micah A ; Longnecker, Richard M.</creatorcontrib><description>Recent evidence has shown that the Epstein-Barr virus (EBV) oncogene LMP1 is not expressed at high levels early after EBV infection of primary B cells, despite its being essential for the long-term outgrowth of immortalized lymphoblastoid cell lines (LCLs). In this study, we found that expression of LMP1 increased 50-fold between 7 days postinfection and the LCL state. Metabolic labeling of nascent transcribed mRNA indicated that this was primarily a transcription-mediated event. EBNA2, the key viral transcription factor regulating LMP1, and CTCF, an important chromatin insulator, were recruited to the LMP1 locus similarly early and late after infection. However, the activating histone H3K9Ac mark was enriched at the LMP1 promoter in LCLs relative to that in infected B cells early after infection. We found that high c-Myc activity in EBV-infected lymphoma cells as well as overexpression of c-Myc in an LCL model system repressed LMP1 transcription. Finally, we found that chemical inhibition of c-Myc both in LCLs and early after primary B cell infection increased LMP1 expression. These data support a model in which high levels of endogenous c-Myc activity induced early after primary B cell infection directly repress LMP1 transcription. EBV is a highly successful pathogen that latently infects more than 90% of adults worldwide and is also causally associated with a number of B cell malignancies. During the latent life cycle, EBV expresses a set of viral oncoproteins and noncoding RNAs with the potential to promote cancer. Critical among these is the viral latent membrane protein LMP1. Prior work suggests that LMP1 is essential for EBV to immortalize B cells, but our recent work indicates that LMP1 is not produced at high levels during the first few weeks after infection. Here we show that transcription of the LMP1 gene can be negatively regulated by a host transcription factor, c-Myc. Ultimately, understanding the regulation of EBV oncogenes will allow us to better treat cancers that rely on these viral products for survival.</description><identifier>ISSN: 0022-538X</identifier><identifier>EISSN: 1098-5514</identifier><identifier>DOI: 10.1128/jvi.01178-17</identifier><identifier>PMID: 29118124</identifier><language>eng</language><publisher>United States: American Society for Microbiology</publisher><subject>Transformation and Oncogenesis</subject><ispartof>Journal of virology, 2018-01, Vol.92 (2)</ispartof><rights>Copyright © 2018 American Society for Microbiology.</rights><rights>Copyright © 2018 American Society for Microbiology. 2018 American Society for Microbiology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c450t-7bcab07e7e960efaa4f023ac5666eac5c77da5122565de73668b196bbef2e613</citedby><cites>FETCH-LOGICAL-c450t-7bcab07e7e960efaa4f023ac5666eac5c77da5122565de73668b196bbef2e613</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5752943/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5752943/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29118124$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Longnecker, Richard M.</contributor><creatorcontrib>Price, Alexander M</creatorcontrib><creatorcontrib>Messinger, Joshua E</creatorcontrib><creatorcontrib>Luftig, Micah A</creatorcontrib><title>c-Myc Represses Transcription of Epstein-Barr Virus Latent Membrane Protein 1 Early after Primary B Cell Infection</title><title>Journal of virology</title><addtitle>J Virol</addtitle><description>Recent evidence has shown that the Epstein-Barr virus (EBV) oncogene LMP1 is not expressed at high levels early after EBV infection of primary B cells, despite its being essential for the long-term outgrowth of immortalized lymphoblastoid cell lines (LCLs). In this study, we found that expression of LMP1 increased 50-fold between 7 days postinfection and the LCL state. Metabolic labeling of nascent transcribed mRNA indicated that this was primarily a transcription-mediated event. EBNA2, the key viral transcription factor regulating LMP1, and CTCF, an important chromatin insulator, were recruited to the LMP1 locus similarly early and late after infection. However, the activating histone H3K9Ac mark was enriched at the LMP1 promoter in LCLs relative to that in infected B cells early after infection. We found that high c-Myc activity in EBV-infected lymphoma cells as well as overexpression of c-Myc in an LCL model system repressed LMP1 transcription. Finally, we found that chemical inhibition of c-Myc both in LCLs and early after primary B cell infection increased LMP1 expression. These data support a model in which high levels of endogenous c-Myc activity induced early after primary B cell infection directly repress LMP1 transcription. EBV is a highly successful pathogen that latently infects more than 90% of adults worldwide and is also causally associated with a number of B cell malignancies. During the latent life cycle, EBV expresses a set of viral oncoproteins and noncoding RNAs with the potential to promote cancer. Critical among these is the viral latent membrane protein LMP1. Prior work suggests that LMP1 is essential for EBV to immortalize B cells, but our recent work indicates that LMP1 is not produced at high levels during the first few weeks after infection. Here we show that transcription of the LMP1 gene can be negatively regulated by a host transcription factor, c-Myc. Ultimately, understanding the regulation of EBV oncogenes will allow us to better treat cancers that rely on these viral products for survival.</description><subject>Transformation and Oncogenesis</subject><issn>0022-538X</issn><issn>1098-5514</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNpVkc1rGzEQxUVISBy3t5yLjjlkU41WH7uXQmPc1MWhpRjTm9DKs6nMencjrQP-7yvXTkhOAzM_3nvDI-QK2C0ALz6vn_0tA9BFBvqEjICVRSYliFMyYozzTObFnwtyGeOaMRBCiXNywUuAArgYkeCyh52jv7EPGCNGugi2jS74fvBdS7uaTvs4oG-zOxsCXfqwjXRuB2wH-oCbKtFIf4Vuj1CgUxuaHbX1gCFt_caGHb2jE2waOmtrdHvRD-Sstk3Ej8c5Jotv08Xkezb_eT-bfJ1nTkg2ZLpytmIaNZaKYW2tqBnPrZNKKUzDab2yEjiXSq5Q50oVFZSqqrDmqCAfky8H2X5bbXDlUuJgG9MfUpnOevP-0vq_5rF7NlJLXoo8CVwfBUL3tMU4mI2PLr2SXu620SQzLnjBxN7r5oC60MUYsH61AWb2LZkfy5n535IBnfBPb6O9wi-15P8ADBCPoA</recordid><startdate>20180115</startdate><enddate>20180115</enddate><creator>Price, Alexander M</creator><creator>Messinger, Joshua E</creator><creator>Luftig, Micah A</creator><general>American Society for Microbiology</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20180115</creationdate><title>c-Myc Represses Transcription of Epstein-Barr Virus Latent Membrane Protein 1 Early after Primary B Cell Infection</title><author>Price, Alexander M ; Messinger, Joshua E ; Luftig, Micah A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c450t-7bcab07e7e960efaa4f023ac5666eac5c77da5122565de73668b196bbef2e613</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Transformation and Oncogenesis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Price, Alexander M</creatorcontrib><creatorcontrib>Messinger, Joshua E</creatorcontrib><creatorcontrib>Luftig, Micah A</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of virology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Price, Alexander M</au><au>Messinger, Joshua E</au><au>Luftig, Micah A</au><au>Longnecker, Richard M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>c-Myc Represses Transcription of Epstein-Barr Virus Latent Membrane Protein 1 Early after Primary B Cell Infection</atitle><jtitle>Journal of virology</jtitle><addtitle>J Virol</addtitle><date>2018-01-15</date><risdate>2018</risdate><volume>92</volume><issue>2</issue><issn>0022-538X</issn><eissn>1098-5514</eissn><abstract>Recent evidence has shown that the Epstein-Barr virus (EBV) oncogene LMP1 is not expressed at high levels early after EBV infection of primary B cells, despite its being essential for the long-term outgrowth of immortalized lymphoblastoid cell lines (LCLs). In this study, we found that expression of LMP1 increased 50-fold between 7 days postinfection and the LCL state. Metabolic labeling of nascent transcribed mRNA indicated that this was primarily a transcription-mediated event. EBNA2, the key viral transcription factor regulating LMP1, and CTCF, an important chromatin insulator, were recruited to the LMP1 locus similarly early and late after infection. However, the activating histone H3K9Ac mark was enriched at the LMP1 promoter in LCLs relative to that in infected B cells early after infection. We found that high c-Myc activity in EBV-infected lymphoma cells as well as overexpression of c-Myc in an LCL model system repressed LMP1 transcription. Finally, we found that chemical inhibition of c-Myc both in LCLs and early after primary B cell infection increased LMP1 expression. These data support a model in which high levels of endogenous c-Myc activity induced early after primary B cell infection directly repress LMP1 transcription. EBV is a highly successful pathogen that latently infects more than 90% of adults worldwide and is also causally associated with a number of B cell malignancies. During the latent life cycle, EBV expresses a set of viral oncoproteins and noncoding RNAs with the potential to promote cancer. Critical among these is the viral latent membrane protein LMP1. Prior work suggests that LMP1 is essential for EBV to immortalize B cells, but our recent work indicates that LMP1 is not produced at high levels during the first few weeks after infection. Here we show that transcription of the LMP1 gene can be negatively regulated by a host transcription factor, c-Myc. Ultimately, understanding the regulation of EBV oncogenes will allow us to better treat cancers that rely on these viral products for survival.</abstract><cop>United States</cop><pub>American Society for Microbiology</pub><pmid>29118124</pmid><doi>10.1128/jvi.01178-17</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0022-538X
ispartof Journal of virology, 2018-01, Vol.92 (2)
issn 0022-538X
1098-5514
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5752943
source EZB-FREE-00999 freely available EZB journals; PubMed Central
subjects Transformation and Oncogenesis
title c-Myc Represses Transcription of Epstein-Barr Virus Latent Membrane Protein 1 Early after Primary B Cell Infection
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T01%3A38%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=c-Myc%20Represses%20Transcription%20of%20Epstein-Barr%20Virus%20Latent%20Membrane%20Protein%201%20Early%20after%20Primary%20B%20Cell%20Infection&rft.jtitle=Journal%20of%20virology&rft.au=Price,%20Alexander%20M&rft.date=2018-01-15&rft.volume=92&rft.issue=2&rft.issn=0022-538X&rft.eissn=1098-5514&rft_id=info:doi/10.1128/jvi.01178-17&rft_dat=%3Cproquest_pubme%3E1962428041%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1962428041&rft_id=info:pmid/29118124&rfr_iscdi=true